Assessing efficacy and tolerability of lamotrigine (Sazar®) in therapy of female idiopathic generalized epilepsy: a multicenter study
Background. Idiopathic generalized epilepsy (IGE) comprises 15–20% among all types of epilepsy. However, specifics of administration for lamotrigine in IGE in the Russian Federation remain poorly investigated, especially in female subjects.Objective: to assess efficacy and potential adverse events (...
Main Authors: | M. V. Barkhatov, I. S. Bakhtin, O. V. Belyaev, M. A. Yamin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2022-01-01
|
Series: | Эпилепсия и пароксизмальные состояния |
Subjects: | |
Online Access: | https://www.epilepsia.su/jour/article/view/744 |
Similar Items
-
The clinical, sociodemographic, and pharmacotherapeutic characteristics influencing quality of life in patients with epilepsy
by: Faheem Nazir Qanoongo, et al.
Published: (2023-01-01) -
Rationale for mono- versus polytherapy with antiepileptic drugs for patients with epilepsy
by: L. V. Lipatova, et al.
Published: (2017-06-01) -
Gender characteristics of therapy for genetic generalized epilepsy in adults
by: I. V. Volkov, et al.
Published: (2020-02-01) -
LAMOTRIGINE USE IN THE TREATMENT OF EPILEPSY IN ELDERLY PATIENTS
by: S. R. Nurmuhametova, et al.
Published: (2016-05-01) -
Rational Polytherapy with Antiepileptic Drugs
by: Jong Woo Lee, et al.
Published: (2010-07-01)